Rutgers Expert Can Discuss Fires in Amazon Rainforests

New Brunswick, N.J. (Aug. 27, 2019) – With numerous fires raging in ecologically priceless Amazon rainforests, Rutgers University–New Brunswick Professor Laura C. Schneider can comment on current fire patterns (the number of fires and their location), linkages to tropical rain…

الكانابيديول (CBD)، قد يكون زيت نبات القنب مفيدًا ولكن هناك حاجة إلى إجراء المزيد من البحوث، وفقًا لما أوضحته مراجعة Mayo Clinic

مدينة روتشستر، مينيسوتا — أصبحت زيوت الكانابيديول (CBD) ومنتجاتها شائعة بشكلٍ متزايد وسط المستهلكين كطرق لتخفيف الأوجاع والآلام والقلق واضطرابات النوم وغيرها من المسائل المزمنة الأخرى. ولكن هل هذه المنتجات آمنة، وهل هي مفيدة؟

Compte-rendu de Mayo Clinic : le CBD, l’huile de chanvre pourraient être utiles mais des recherches supplémentaires sont nécessaires

Les huiles de cannabidiol (CBD) et leurs produits dérivés sont devenus de plus en plus populaires auprès des consommateurs, qui peuvent ainsi soulager leurs douleurs, l’anxiété, les troubles du sommeil et d’autres problèmes chroniques. Mais ces produits sont-ils sans danger et sont-ils utiles ?

Knowledgebase is power for nuclear reactor developers

Six new nuclear reactor technologies are planned to commercially deploy between 2030 and 2040. ORNL’s Weiju Ren heads a project managing structural materials information. This conversation explores challenges and opportunities in sharing nuclear materials knowledge internationally.

$1.75 million X-ray tool is first of its kind in the U.S.

Binghamton University, State University of New York will acquire a sophisticated new X-ray tool useful in materials research and R&D for electronics. The $1.75 million system — the third of its kind in the world and the first outside of Europe — will be funded by $1.23 million from the National Science Foundation’s Major Research Instrumentation program and additional money from the campus.

New Drug Combination Shows Promising Activity in Non-Small Cell Lung Cancer Patients

Patients with non-small cell lung cancer (NSCLC) now have more improved treatment options compared to standard of care with the addition of several new agents called immune-checkpoint inhibitors (ICI). Despite these changes, many patients still develop progressive disease after ICI treatment. In a new study published in Clinical Cancer Research, Moffitt Cancer Center researchers describe promising results from an early clinical trial that may offer patients who progress after ICI an additional treatment option.

Medicare Part D and the Affordable Care Act Have Shifted Direct Expenditures for Medications from US Consumers to Insurers and Public Payers

Value in Health, the official journal of ISPOR, announced today the publication of new research showing that while expenditures for prescribed medicines have risen significantly in the United States for the past 2 decades, expanded prescription drug coverage has resulted in a significant reduction in patient out-of-pocket drug costs.

Gold nanoparticles shown to be safe and effective treatment for prostate cancer

Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate, according to a study conducted at the Icahn School of Medicine and published in the…

PSU receives $19.3 million NIH grant to help underserved students become scientists

The National Institutes of Health (NIH) has awarded an additional $19.3 million grant to a successful Portland State University (PSU) program that helps students from socioeconomically disadvantaged backgrounds become top-level health sciences researchers. The program – Building Infrastructure Leading to…